Eurofins Scientific SE (ENXTPA:ERF) acquired Ascend Clinical, LLC on April 3, 2024. Patti Hunsader, the current chief operating officer of Ascend, will assume the role of President of Ascend Clinical. The existing leadership of the company will remain in place, continuing to drive the organization's growth as part of the Eurofins clinical diagnostics business line in the United States.

Eurofins Scientific SE (ENXTPA:ERF) completed the acquisition of Ascend Clinical, LLC on April 3, 2024.